Based on these analyses, ESR1, CYP1A2, and AURKA were identified as key genes, and their significant roles in HCC progression and prognosis were validated through immune infiltration, drug sensitivity analysis, and survival curves [86]. This evidence concerns the gene AURKA and hepatocellular carcinoma.